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• Junctional injuries were predominantly severe. METHODS: The Wake Forest University human cadaver hemostasis model was used to test the efficacy of the CRC. This testing platform uses a pulsatile peristaltic pump to produce realistic constant blood flow within the arteries of a fresh unembalmed human cadaver. Testing hemostatic devices and procedures using intact fresh human tissue has some advantages over alternative live tissue models when a mechanical device is employed to reduce arterial flow rates. Authentic human anatomy is an important requirement for validating the efficacy of hemorrhage control devices when an external control clamp device is applied to control flow in the external iliac artery at or above the inguinal ligament where peripheral limb tourniquet application cannot be used. In this feasibility study, peristaltic tubing was inserted and sealed within the thoracic aorta in 2 different unembalmed fresh human cadavers. An external peristaltic pump was used to deliver fluid through arteries in the descending abdomen, pelvis and limbs of the cadaver with a constant peristaltic speed and constant arterial flow rate consistent with physiological levels. The right popliteal artery was cut in order to measure dynamic changes in downstream arterial flow rates from fluid pumped through the thigh before, during and after the application of hemorrhage control devices with constant peristaltic pumping. In addition, a pressure transducer was inserted into the right femoral artery to accurately measure dynamic changes in limb arterial pressure before, during and after the application of the hemorrhage control devices against the constant pressure from the peristaltic pump. A Combat Application Tourniquet (CAT) was used first in control trials to demonstrate the validity of this testing system. The CAT was applied to the thigh to validate measurements of hemorrhage control from the popliteal artery. The CAT was removed and the CRC was then applied to the external iliac artery above the inguinal ligament. Experimental endpoints included the measurement of changes in arterial flow rates and alterations in arterial pressure measure before, during and after the application of the CRC to the external iliac artery.
Junctional Extremity Injury Severity Rate
RESULTS:
The human hemostatic testing model developed at the Wake Forest University
School of Medicine was used to demonstrate the capacity of the CRC to stop arterial flow when applied to the external iliac artery. The CRC completely stopped blood flow and arterial pressure with only 4 to 9 turns of the device when the clamp is applied to the surface of the cadaver abdomen above the inguinal ligament. The CRC controlled arterial flow through the external iliac in three trials in both cadavers. use in the battlefield to control difficult bleeds in the inguinal area. The aluminum device weighs about 1.6 lb and comes partially assembled for folding flat in the medic's aid bag. For use, the medic attaches the horizontal arm, the pressure handle and the pressure disk (Fig 1 ) . The vertical and horizontal arms can be adjusted for exact placement on the wound and the pressure handle is tightened to pressurize the wound with the pressure disc. The medic then uses the strap to go around the casualty to prevent the CRC from slipping. The following experiment was designed to test the feasibility of the CRC in controlling hemorrhage to the external iliac artery at or above the inguinal ligament.
Inclusion/Exclusion Criteria
Two Human Cadavers were used in this experiment with a weight range 130lbs-200lbs. The cadavers had no grafts and no vascular surgeries in the abdominal aorta, iliac or femoral vessels.
The cadavers were not embalmed and were not frozen but instead they were refrigerated after 0 death and maintained at a constant temperature above freezing which ranged from 2.2 to 3.3 C prior to use. Both cadavers were used within one week of death. The cadavers were placed at ambient temperature 4 hours prior to testing.
Methods
While live tissue animal models (i.e. porcine studies) are perhaps ideal for studying the hemostatic properties of blood clotting chemicals and agents, externally applied clamping devices that rely upon mechanical occlusion of blood vessels to reduce and stop blood flow require authentic human anatomy for optimal testing. Cadaver I was approximately 60 year old male with a total body mass of 17S lbs. Cadaver II was approximately 70 year old female with a total body mass of 11 Olbs. Cadavers were inspected for presence of surgeries in the areas to be 
Cadaver II
In cadaver II the results were remarkably similar with cadaver I over multiple trials.
Representative recordings of femoral pressure are provided below (Fig 7) . In this cadaver approximately nine turns of the device handle were required to achieve complete hemostasis.
Note the application of the CRC device quickly reduced flow through the external iliac to reduce measurements of femoral pressure. Hemostasis was held stable by the device for the 90 seconds so that when the device was later released there was an immediate recovery of fluid flow and femoral arterial pressure. · rr ~e of preventable death on the battlefield is hemorrhage. 1 Effective use of increase survival in combat, yet control of truncal bleeding remains a was specifically designed to control direct injury to the femoral artery in the inguinal area, or high traumatic amputation too proximal for regular extremity tourniquets.
Combat Ready Clamp (CRoC)
The CRoC is mainly used on 3 different surface types: hard and flat like the ground or a floor; on a hospital bed or gurney if applied in a hospital; and on a NATO litter when used during evacuation. The Manikin preparation included: 1) infusion of simulated blood ( 4,000 ml tap water, 60 ml rubbing alcohol, 30 ml simulated blood to tint fluid) into CRoC manikin according to manufacturer's recommendations; 2)
for every 1,000 ml of simulated blood out during the experiment, 1,000 ml of simulated blood was reinfused to maintain a relatively constant internal bladder pressure; 3) a plastic drainage board under the manikin directed simulated bleeding from both anterior and posterior proximal thigh wounds into a bucket. (Figure 2 ) 2) Vertical ann offset distance from vertical arm to torso was measured in em using a ruler.
3) Estimated blood loss (EBL) recovered from manikin drainage was measured in milliliters. 
Results
All six individuals successfully completed 3 iterations on each of the three experimental surfaces (n = 54). The CRoC effectively achieved hemorrhage controllOO% of the time (54/54). Patient surface did affect time to achieve hemorrhage control. The soft surface (55± 9.7 seconds) was significantly different from the litter (65 ± 16.5 seconds) and had the lowest overall total time (p = 0.007); time for the hard surface was 58± 9.5 seconds. Mean time to control hemorrhage for all surfaces combined was 59± 12.9 seconds. Mean time to assemble CRoC was 33 ± 7.4 seconds; time to position was 12 ± 4.8 seconds;
and time to control bleeding was 15 ± 7.5 seconds.
Although 4 of 6 users improved time to achieve hemotThage control over the three iterations, there was no statistical difference in overall iteration time (p > 0.05). There was a difference in individual user time to achieve hemorrhage control; User F was different from the others (p < 0.0001) (Figure 3 ). 1 3 1 1 2 13 1 1 2 1 3 1 1 2 13 1 12 1 3 1 1 2 1 3 User A User 8
UserC User D User E ranged from 0 to 6 em (2.14 ± 1.5) with 14/5 1 cases~ 3 em from target (27%). 
Conclusions
I. The CRoC achieved hemorrhage control I 00% of the time using a manikin specifically designed to test the device. Positioning of device can be up to 6 em from target (directly over femoral artery) with successful hemorrhage control.
2. Patient surface type affected CRoC ability of user to achieve hemorrhage control; the soft padded surface was associated with the most rapid control of bleeding, followed by the hard surface and then the NATO litter.
3. Human simulation is a practical and useful method for training and evaluation ofCRoC user performance.
4. Several refinements to the CRoC training materials and video are recommended to decrease time to achieve hemorrhage control, to include: storage of device in a manner that speeds assembly in the field; mark vertical arm with a target to guide rapid extension of arm to optimal position (approximately the last three holes); positioning the horizontal arm to target inguinal area; and necessity to achieve control of bleeding prior to adjusting or positioning the safety strap.
User performance affects device performance. 3 Future research efforts will evaluate the number of practice iterations will be required for a novice CRoC user, and to determine frequency of refresher training to maintain proficiency. The hemorrhage from junctional wound, however, has become more lethal and pertinent in the current conflicts due to improvised explosive device (lED) explosions. The most common type of junctional bleeding occurs in groins wound where regular TQ cannot be placed effectively. A collaborative effort of several organizations has led to development of a mechanical device, known as the Combat Ready Clamp (CRoC), to address junctional bleeding. The CRoC was designed to exert mechanical pressure directly over the wound or indirectly over skin and deeper tissues to occlude underlying blood vessels and stop external or internal bleedings. However, the instrument has not been tested in live subjects with uncontrolled hemorrhage. Objective: To examine the feasibility and effectiveness of CRoC to control arterial hemorrhage in our standard groin injury model in swine with a pre-existing coagulopathy. Methods: Six Yorkshire pigs ( 40.1 ± 2.4 kg) were anesthetized, mechanically ventilated and subjected to midline laparotomy. Splenectomy was then performed, fluid replacement administered (3X lactated Ringers), and the abdominal incision closed with suturing. Next, the femoral artery was dissected and prepared for injury. To induce coagulopathy, each animal was subjected to 50% isovolemic blood exchange with Hextend and 4°C hypothermia (core temperature= 34.5° C). Prior to injury, the CRoC was partially assembled and placed beneath and next to the pig. The CRoC's pressure disk was also aligned with the artery to ensure that the pressure is directly exerted on the injury site when the device is applied. Next, vascular injury (6 mm hole) was made on the femoral artery and free bleeding was allowed for 15 seconds for measuring pre-treatment blood loss. The groin wound was then packed with 10 layers of 4"x4" surgical gauze, covered with a folded laparotomy sponge and compressed manuaJiy for 2 minutes. Afterwards, the wound was observed for 2 minutes and once rebleeding became evident (no hemostasis), the remaining parts of the CRoC (horizontal arm, pressure screw and disc) were assembled and the disc was rapidly screwed down to exert enough pressure to stop the hemorrhage. The CRoC was left in place for I hr and any blood loss during this period and during the application procedure was collected and measured. At I hr, the animal was scanned by CT methods and images of blood c irculation through its lower body blood vessels were obtained. The hind legs were then flexed and stretched five times to mimic walking motions and to determine the stability of the CRoC to maintain hemostasis. Next, the clamp was removed and the wound was observed for another hour or less until the animal exsanguinated. Blood loss during this period was also measured for comparison with the period that the clamp was applied (i.e., control). Limited fluid resuscitation (maximum of 3 liters Hextend at 50 ml/ min) was administered as needed to maintain MAP at or above 65 mmHg.
Title: In Vivo
Results:
The arterial injury caused profuse bleeding with an average blood loss of 126 ml in 15 seconds before treatment. Application of the CRoC (final assembly and tightening the screw) took an average of 90 seconds which stopped the hemorrhage and prevented rebleeding during the I hr observation in all animals (n=6). This was accomplished by setting up the CRoC at its lowest height and screwing down the pressure disk almost entirely to generate sufficient pressure to secure hemostasis. This pressure was 800-900 mmHg as measured with a digital barometer and pneumatic cuff that was placed beneath the pressurizing disk. Almost all blood loss during the first hr of observation ( -90 ml) occurred during the application of the CRoC with minimal oozing afterwards. Blood pressure (MAP) remained at or above 65 mm Hg (Fig. 1) and a minimal volume of fluid was administered during this period. Walking simulation also did not cause slippage of the clamp or rebleeding. Removal of clamp at 1 hr, however, promptly led to rebleeding in 5 out of 6 experiments and animals exsanguinated during the second hour of observation despite receiving resuscitation fluid. Rebleeding did not occur in one experiment after removal of the clamp possibly due to tight packing of the gauze in the wound when the CRoC was applied. The overall hemostatic results are shown in table 1. Blood test results are summarized in table 2 . The data collectively show the effectiveness of the CRoC in preventing hemorrhagic shock and maintaining homeostasis in pigs with a lethal vascular injury. CT scans and Doppler tests of hind legs showed no evidence of blood flow in the distal tissues when the clamp was applied on the groin wound. Moreover, the CT images of the arteries revealed complete occlusion of external and internal iliac arteries above (proximal) the CRoC-applied area and no collateral circulation in proximal and distal tissues. The images of a representative experiment before application (baseline) and after application of the CRoC are shown in Fig. 2 . Histological examination of tissues (local muscle, femoral artery, vein and nerve) showed no apparent damage associated with acute application of the CRoC. Only focal inflammatory cell (PMNs) infiltration was seen on the endothelium layer of femoral veins and in perineural tissues of femoral nerve. These insignificant findings were expected given the short duration ofCRoC application and the absence of blood reflow and functional tests of the compressed tissues.
It was intended to use one CRoC repeatedly for performing the entire study; however, after five usages the pressure screw was damaged and could not be turned to release/operate the clamp in normal way. A second clamp was then used for the last two experiments which also developed the same problem after three applications. Summary: Application ofCRoC over gauze in the pig groin wound consistently stopped a lethal arterial bleeding that could not be managed with dressing alone. These results indicate that the CRoC is a powerful hemostatic adjunct and can potentially be useful for treating some junctional bleedings. In the present study, the CRoC applied pressure was substantially higher (~ 10 X) at the injury site tban the animals' systolic pressure in order to control hemorrhage. Such high pressure effectively occluded major extremity arteries (external and internal iliac vessels) and prevented collateral circulation in the affected leg. Applying the clamp with such high pressure also caused metal damages (screw thread) and made the instrument inoperable after a few tests. Histological examination of tissues showed no significant acute damages in blood vessels and nerves after a 1 hour compression with the CRoC. The long-term effects of CRoC application and total ischemia induced by this device on limb function remains unknown and warrant further investigation.
Conclusions:
1. Application of CRoC on a pig groin wound consistently and securely (no slippage) stopped a lethal arterial hemorrhage.
2. In order to stop the junctional hemorrhage, the CRoC had to be applied at significantly higher pressure {"'lOX ) than systolic pressure. Data expressed as mean ± SEM. Immediately following death, they were exsanguinated, eviscerated, and perfused to remove all blood. Branches of the aorta that were cut during organ removal were ligated or clamped. They were then refrigerated overnight.
On the following day, a Statham dome was connected to the left femoral artery for recording arterial pressure. A transit time flow probe was placed on the right external iliac artery for recording flow. A pulsatile blood pump for large animals was connected to the aorta. Pressure and flow measurements were made during simulated hemorrhage. Flow rate was varied as shown in Table 1 . The pump was turned on and simulated bleeding from a deep incision in the groin area was created ( Figure 1) .
Results:
Hydrostatic pressure (blue) was recorded from the left femoral artery and flow (red) was recorded from the right external iliac artery (Figure 2 ). Pump stroke rate and volume were varied to achieve different pressures and flows as shown in Table 1 .
When the pump was turned on after creating the injury, the pressure increased and caused high flow bleeding in the wound (Figure 2 , Pump on).
When the CRoC was applied, intravascular pressure increased and outflow (bleeding) dropped to zero ml/min. (Figure 2 , CRoC applied).
When the CRoC was removed, rebleeding started and as a result pressure dropped (Figure 2 , CRoC released).
The flat segment on the RED line showed that flow (bleeding) reduced to ZERO when the CRoC was fully applied (Figure 2 ). Table 1 ) .
The CRoC failed on the eleventh application in the perfused swine carcass model when the device's t-arm (T-handle) became bound ( Figure 3 ). Application of more force damaged the threads on the T -arm and produced metal shavings.
Conclusion:
The CRoC is effective in controlling junctional hemorrhage in a perfused swine carcass model. The CRoC is designed for one-time use. Repetitive use of the device in the perfused swine carcass model resulted in instrument failure. Communication with investigators using the CRoC in other models revealed that similar failure of the CRoC occurred in the live swine model, but was not seen in a human manikin model. Further study is needed to estimate failure rate.
